LuciVenet (Venetoclax) in London, Washington USA, Canberra Australia, Singapore and Manila Philippines

LuciVenet is used for treating chronic lymphocytic leukemia (CLL) and other blood cancers. Active Ingredient Venetoclax inhibits BCL-2 protein, which helps cancer cells survive. Uses of LuciVenet • Chronic lymphocytic leukemia • Acute myeloid leukemia How LuciVenet Works It promotes apoptosis by blocking BCL-2 protein. How to Use LuciVenet • Dose escalation required • Take with food Possible Side Effects • Neutropenia • Diarrhea Precautions • Risk of tumor lysis syndrome • Monitor blood tests Safety Information Strict medical supervision required. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciSelin is used in treating multiple myeloma and certain lymphomas, especially in advanced stages. Active Ingredient Selinexor inhibits nuclear export protein XPO1. Uses of LuciSelin • Multiple myeloma • Lymphoma How LuciSelin Works It traps tumor suppressor proteins inside the nucleus, leading to cancer cell death. How to Use LuciSelin • Take on scheduled days Possible Side Effects • Nausea • Fatigue • Low blood counts Precautions • Monitor blood counts Safety Information Use under strict supervision. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciSel is used in RET fusion-positive cancers including lung and thyroid cancers. Active Ingredient Selpercatinib inhibits RET kinase activity. Uses of LuciSel • RET-positive lung cancer • Thyroid cancer How LuciSel Works Blocks RET-driven tumor growth pathways. How to Use LuciSel • Take twice daily Possible Side Effects • Dry mouth • Hypertension Precautions • Monitor liver function Safety Information Requires regular monitoring. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children